KEMPHARM, INC Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 1, 2024)
- Contingent Value Rights Agreement, dated as of November 17, 2023, by and among Zevra Therapeutics, Inc., Computershare, Inc., and Computershare Trust Company, N.A (Filed With SEC on November 20, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 7, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2022)
- Form of Inducement Letter (Filed With SEC on June 23, 2021)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2021)
- Payoff letter, dated as of February 8, 2021, by and among the Company and the lenders named therein (Filed With SEC on February 9, 2021)
- Form of Inducement Letter (Filed With SEC on January 26, 2021)
- Amended and Restated Bylaws of KemPharm, Inc., effective as of July 15, 2020 (Filed With SEC on July 17, 2020)
- Agreement to Terminate CLA, by and between MonoSol Rx, LLC and the Registrant, dated as of March 20, 2012 (Filed With SEC on November 14, 2019)
- THIRD AMENDMENT (Filed With SEC on March 10, 2017)
- SECOND AMENDMENT (Filed With SEC on March 10, 2017)
- FIRST AMENDMENT (Filed With SEC on March 10, 2017)